Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)

SHA:688273 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	309.91	461.56	991.63	1,176	272.62	149.82
Trading Asset Securities	500.47	433.42	105.65	40	-	-
Cash & Short-Term Investments	810.38	894.98	1,097	1,216	272.62	149.82
Cash Growth	-11.98%	-18.44%	-9.75%	345.98%	81.97%	46.95%
Accounts Receivable	36.69	17.79	11.41	26.84	10.18	19.46
Other Receivables	1.55	1.16	1.47	1.46	0.3	0.33
Receivables	38.24	18.94	12.88	28.3	10.48	19.78
Inventory	63.36	73.05	55.02	68.59	38.49	21.23
Prepaid Expenses	-	0.16	-	-	-	-
Other Current Assets	16.43	14.52	6.67	7.9	19.69	7.41
Total Current Assets	928.4	1,002	1,172	1,321	341.28	198.25
Property, Plant & Equipment	390.74	327.42	207.59	154.73	123.82	118.06
Long-Term Investments	97.13	98.73	79.7	0.56	0.44	1.28
Goodwill	41.9	41.9	0.91	0.91	0.91	0.91
Other Intangible Assets	49.06	55.61	31.21	18.5	7.19	7.57
Long-Term Deferred Tax Assets	16.97	9.49	9.99	6.14	6.47	4.92
Long-Term Deferred Charges	16.46	8.13	5.27	6.59	8.03	1.45
Other Long-Term Assets	0.75	3.69	27.4	3.88	0.59	1.49
Total Assets	1,541	1,547	1,534	1,512	488.74	333.92
Accounts Payable	20.35	17.04	9.16	12.57	13.09	9.68
Accrued Expenses	15.36	37.65	23.97	26.6	32.64	22.72
Short-Term Debt	6.01	7.01	-	-	-	7.35
Current Portion of Leases	-	2.94	6.13	1.44	2.12	-
Current Income Taxes Payable	10.26	0.68	3.45	9.26	5.12	6.12
Current Unearned Revenue	27.09	51.27	45.66	47.98	33.3	24.4
Other Current Liabilities	26.16	46.38	44.86	25.7	13.85	12.31
Total Current Liabilities	105.22	162.96	133.24	123.55	100.11	82.58
Long-Term Leases	10.42	0.65	2.37	7.99	4.1	-
Long-Term Unearned Revenue	15.82	15.94	17.75	6.03	10.44	2.32
Long-Term Deferred Tax Liabilities	4.29	5.46	5.25	4.39	1.36	1.56
Other Long-Term Liabilities	10.92	14.64	-	-	-	-
Total Liabilities	146.67	199.66	158.6	141.96	116.01	86.46
Common Stock	100	100	100.62	100	75	75
Additional Paid-In Capital	984.66	984.54	999.45	982.7	92.55	87.85
Retained Earnings	336.78	279.91	276.8	267.48	195.95	77.57
Treasury Stock	-53.58	-52.25	-31.09	-	-	-
Total Common Equity	1,368	1,312	1,346	1,350	363.5	240.42
Minority Interest	26.88	34.76	29.54	19.77	9.24	7.04
Shareholders' Equity	1,395	1,347	1,375	1,370	372.74	247.47
Total Liabilities & Equity	1,541	1,547	1,534	1,512	488.74	333.92
Total Debt	16.43	10.6	8.51	9.43	6.22	7.35
Net Cash (Debt)	793.95	884.38	1,089	1,206	266.4	142.47
Net Cash Growth	-12.27%	-18.77%	-9.75%	352.86%	86.98%	66.34%
Net Cash Per Share	8.11	8.98	10.89	14.48	3.55	1.90
Filing Date Shares Outstanding	97.81	97.81	99.51	100	75	75
Total Common Shares Outstanding	97.81	97.86	100.62	100	75	75
Working Capital	823.18	838.7	1,039	1,197	241.17	115.67
Book Value Per Share	13.99	13.41	13.37	13.50	4.85	3.21
Tangible Book Value	1,277	1,215	1,314	1,331	355.4	231.95
Tangible Book Value Per Share	13.06	12.41	13.06	13.31	4.74	3.09
Buildings	-	112.1	112.1	112.1	112.1	109.25
Machinery	-	53.53	44.39	37.31	21.95	16.15
Construction In Progress	-	203	77.04	19.99	-	2.38

Source: S&P Global Market Intelligence. Standard template. Financial Sources.